Basal cell carcinomas: p53-dependent mechanisms of resistance

基底细胞癌：p53 依赖性耐药机制

• 批准号: 8825460
• 负责人: Ervin HAROLD Epstein
• 金额: $ 33.62万
• 依托单位: CHILDREN'S HOSPITAL & RES CTR AT OAKLAND
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-04-01 至 2016-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8825460
• 关键词: Accounting; Address; Alleles; Automobile Driving; Basal Cell; Basal Cell Nevus Syndrome; Basal cell carcinoma; Cells; Characteristics; Clinical; DNA Damage; Development; Frequencies; Genetic; Goals; Hair follicle structure; Human; Malignant Neoplasms; Mediating; Missense Mutation; Modeling; Molecular Abnormality; Mus; Mutation; Nevus; Oncogenic; Pathway interactions; Patients; Population; Prevention; Relative (related person); Reporter; Resistance; Role; Signal Pathway; Signal Transduction; Skin; Skin Cancer; Squamous cell carcinoma; Stem cells; Tissues; Tumor Suppression; Tumor-Derived; Visceral; cancer type; carcinogenesis; cell transformation; clinically significant; gain of function mutation; keratinocyte; loss of function; loss of function mutation; mouse model; mutant; prevent; resistance mechanism; response; smoothened signaling pathway; tumor; tumorigenesis; tumorigenic

DESCRIPTION (provided by applicant): The goal of this project is to understand better the mechanisms of intrinsic tumor suppression that inhibit cells carrying oncogenic mutations from developing into clinically significant cancers. This suppression is of limited efficacy in preventing basal cell carcinogenesis, as it is by far the most common human cancer. Nonetheless mouse modeling indicates the presence of very strong p53-dependent anti-BCC effects, and human BCCs routinely carry p53 mutations. We (i) will investigate the connections by which mutation-driven activated hedgehog signaling, the pivotal abnormality in BCC carcinogenesis, activates p53's anti-cancer effects (ii) will elucidate the differences between the pro-carcinogenic effects of p53 loss of function mutations (as occur in human BCCs in PTCH1/basal cell nevus syndrome patients) and p53 gain of function mutations (as occur in human BCCs occurring sporadically) and (iii) will compare the effects of p53-dependent tumor suppression on the hair follicle tissue stem cells carrying mutations of hedgehog signaling vs. carrying mutant alleles activating oncogenic pathways that commonly underlie cancers of other tissues but not of skin. Successful prosecution of this Project will help elucidate why this "outlier" cancer is so common, why different genetic backgrounds can influence the type of p53 mutation found, and why specific tissues and cells are transformed by characteristic oncogenic pathways.

描述(申请人提供)：这个项目的目标是更好地了解内在的肿瘤抑制机制，这种机制抑制携带癌基因突变的细胞发展成具有临床意义的癌症。这种抑制在预防基底细胞癌方面的效果有限，因为它是迄今为止最常见的人类癌症。尽管如此，小鼠模型显示存在非常强的依赖于p53的抗基底细胞癌效应，而人类基底细胞癌通常携带p53突变。我们(I)将研究突变驱动激活的Hedgehog信号--基底细胞癌发生中的关键异常--激活P53‘S抗癌效应的联系；(Ii)我们将阐明P53功能缺失突变(如在PTCH1/基底细胞痣综合征患者中发生在人BCC中)和P53功能突变获得(如零星发生在人BCC中)的促癌作用之间的差异；以及(Iii)将比较携带Hedgehog信号突变的毛囊组织干细胞和携带突变的等位基因激活致癌途径的毛囊组织干细胞之间的差异，后者通常是其他组织而不是皮肤癌的潜在致癌途径。该项目的成功开展将有助于阐明为什么这种“异常值”癌症如此常见，为什么不同的遗传背景会影响所发现的p53突变的类型，以及为什么特定的组织和细胞会通过独特的致癌途径转化。